NCT02134808View on ClinicalTrials.gov

Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 21, 2014

Primary Completion Date

June 27, 2017

Study Completion Date

June 27, 2017

Conditions
Major Depressive Disorder
Interventions
DRUG

Creatine

Creatine is a nutritional supplement.

DRUG

Placebo

The placebo is an inactive ingredient similar in appearance, weight and density to the active treatment.

Trial Locations (1)

84108

University of Utah School of Medicine, Salt Lake City

All Listed Sponsors
lead

Perry Renshaw

OTHER

NCT02134808 - Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder | Biotech Hunter | Biotech Hunter